1. A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing

   • Ulf Persson
   • Johanna Svensson
   • Billie Pettersson

   Current Opinion 12 December 2012 Pages: 217 - 225

   

2. Economic Consequences of the Demography of MRSA Patients and the Impact of Broad-Spectrum Antimicrobials

   • Klaus Kaier
   • S. Moog

   Short Communication 12 December 2012 Pages: 227 - 234

   

3. Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany

   • Michael Bäumler
   • Tom Stargardt
   • Reinhard Busse

   Original Research Article 12 December 2012 Pages: 235 - 248

   

4. Resource Utilization and Outcomes in Patients with Atrial Fibrillation

   • Rachael Boggon
   • Gregory Y. H. Lip
   • Tjeerd P. van Staa

   Original Research Article 12 December 2012 Pages: 249 - 259

   

5. Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece

   • Georgia Kourlaba
   • Vassilis Fragoulakis
   • Nikos Maniadakis

   Original Research Article 12 December 2012 Pages: 261 - 271

   

6. Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures

   • Avram A. Edidin
   • Kevin L. Ong
   • Steven M. Kurtz

   Original Research Article 12 December 2012 Pages: 273 - 284